<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-02-01" modified="2024-10-02" version="193" xmlns="http://uniprot.org/uniprot">
  <accession>Q7KZF4</accession>
  <accession>Q13122</accession>
  <accession>Q96AG0</accession>
  <name>SND1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Staphylococcal nuclease domain-containing protein 1</fullName>
      <ecNumber evidence="9 10">3.1.31.1</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>100 kDa coactivator</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>EBNA2 coactivator p100</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Tudor domain-containing protein 11</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>p100 co-activator</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">SND1</name>
    <name type="synonym">TDRD11</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="4735" last="4744">
      <title>The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.</title>
      <authorList>
        <person name="Tong X."/>
        <person name="Drapkin R."/>
        <person name="Yalamanchili R."/>
        <person name="Mosialos G."/>
        <person name="Kieff E."/>
      </authorList>
      <dbReference type="PubMed" id="7651391"/>
      <dbReference type="DOI" id="10.1128/mcb.15.9.4735"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>PROTEIN SEQUENCE OF 234-249; 567-586; 642-651; 679-704 AND 788-818</scope>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH EBNA2 (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH GTF2E1 AND GTF2E2</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="2">
    <citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
      <title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
      <authorList>
        <person name="Kalnine N."/>
        <person name="Chen X."/>
        <person name="Rolfs A."/>
        <person name="Halleck A."/>
        <person name="Hines L."/>
        <person name="Eisenstein S."/>
        <person name="Koundinya M."/>
        <person name="Raphael J."/>
        <person name="Moreira D."/>
        <person name="Kelley T."/>
        <person name="LaBaer J."/>
        <person name="Lin Y."/>
        <person name="Phelan M."/>
        <person name="Farmer A."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <source>
      <tissue>Lymph</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="submission" date="2008-12" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Zebisch A."/>
        <person name="Kolch W."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 2-21; 48-55; 72-83; 108-136; 178-184; 328-339; 347-359; 516-523; 527-539; 642-651; 716-731; 777-787; 811-819 AND 874-886</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
    <scope>ACETYLATION AT ALA-2</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2002" name="EMBO J." volume="21" first="4950" last="4958">
      <title>Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.</title>
      <authorList>
        <person name="Yang J."/>
        <person name="Aittomaeki S."/>
        <person name="Pesu M."/>
        <person name="Carter K."/>
        <person name="Saarinen J."/>
        <person name="Kalkkinen N."/>
        <person name="Kieff E."/>
        <person name="Silvennoinen O."/>
      </authorList>
      <dbReference type="PubMed" id="12234934"/>
      <dbReference type="DOI" id="10.1093/emboj/cdf463"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH STAT6 AND POLR2A</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1998" name="Mol. Cell" volume="2" first="417" last="425">
      <title>Pim-1 kinase and p100 cooperate to enhance c-Myb activity.</title>
      <authorList>
        <person name="Leverson J.D."/>
        <person name="Koskinen P.J."/>
        <person name="Orrico F.C."/>
        <person name="Rainio E.-M."/>
        <person name="Jalkanen K.J."/>
        <person name="Dash A.B."/>
        <person name="Eisenman R.N."/>
        <person name="Ness S.A."/>
      </authorList>
      <dbReference type="PubMed" id="9809063"/>
      <dbReference type="DOI" id="10.1016/s1097-2765(00)80141-0"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH PIM1</scope>
    <scope>PHOSPHORYLATION BY PIM1</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2003" name="J. Gen. Virol." volume="84" first="2317" last="2322">
      <title>Equine arteritis virus non-structural protein 1, an essential factor for viral subgenomic mRNA synthesis, interacts with the cellular transcription co-factor p100.</title>
      <authorList>
        <person name="Tijms M.A."/>
        <person name="Snijder E.J."/>
      </authorList>
      <dbReference type="PubMed" id="12917451"/>
      <dbReference type="DOI" id="10.1099/vir.0.19297-0"/>
    </citation>
    <scope>INTERACTION WITH EAV NSP1 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2003" name="Nature" volume="425" first="411" last="414">
      <title>A micrococcal nuclease homologue in RNAi effector complexes.</title>
      <authorList>
        <person name="Caudy A.A."/>
        <person name="Ketting R.F."/>
        <person name="Hammond S.M."/>
        <person name="Denli A.M."/>
        <person name="Bathoorn A.M."/>
        <person name="Tops B.B."/>
        <person name="Silva J.M."/>
        <person name="Myers M.M."/>
        <person name="Hannon G.J."/>
        <person name="Plasterk R.H."/>
      </authorList>
      <dbReference type="PubMed" id="14508492"/>
      <dbReference type="DOI" id="10.1038/nature01956"/>
    </citation>
    <scope>ASSOCIATION WITH THE RISC COMPLEX</scope>
    <scope>INTERACTION WITH AGO2 AND FMR1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
      <title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
      <authorList>
        <person name="Rush J."/>
        <person name="Moritz A."/>
        <person name="Lee K.A."/>
        <person name="Guo A."/>
        <person name="Goss V.L."/>
        <person name="Spek E.J."/>
        <person name="Zhang H."/>
        <person name="Zha X.-M."/>
        <person name="Polakiewicz R.D."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="15592455"/>
      <dbReference type="DOI" id="10.1038/nbt1046"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
      <title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
      <authorList>
        <person name="Chi A."/>
        <person name="Valencia J.C."/>
        <person name="Hu Z.-Z."/>
        <person name="Watabe H."/>
        <person name="Yamaguchi H."/>
        <person name="Mangini N.J."/>
        <person name="Huang H."/>
        <person name="Canfield V.A."/>
        <person name="Cheng K.C."/>
        <person name="Yang F."/>
        <person name="Abe R."/>
        <person name="Yamagishi S."/>
        <person name="Shabanowitz J."/>
        <person name="Hearing V.J."/>
        <person name="Wu C."/>
        <person name="Appella E."/>
        <person name="Hunt D.F."/>
      </authorList>
      <dbReference type="PubMed" id="17081065"/>
      <dbReference type="DOI" id="10.1021/pr060363j"/>
    </citation>
    <scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Melanoma</tissue>
    </source>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-909</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-193 AND LYS-641</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-781</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
      <title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Sumpton D."/>
        <person name="Martinez A."/>
        <person name="Lilla S."/>
        <person name="Espagne C."/>
        <person name="Meinnel T."/>
        <person name="Giglione C."/>
      </authorList>
      <dbReference type="PubMed" id="22223895"/>
      <dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103; THR-240; SER-426; SER-645; THR-779; SER-781; SER-785 AND SER-909</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-426; THR-779; SER-781 AND SER-909</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-513</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2017" name="Science" volume="356" first="859" last="862">
      <title>Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition.</title>
      <authorList>
        <person name="Elbarbary R.A."/>
        <person name="Miyoshi K."/>
        <person name="Myers J.R."/>
        <person name="Du P."/>
        <person name="Ashton J.M."/>
        <person name="Tian B."/>
        <person name="Maquat L.E."/>
      </authorList>
      <dbReference type="PubMed" id="28546213"/>
      <dbReference type="DOI" id="10.1126/science.aai9372"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ASSOCIATION WITH THE RISC COMPLEX</scope>
    <scope>INTERACTION WITH AGO2 AND TNRC6A</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2023" name="Cell" volume="186" first="1" last="17">
      <title>SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.</title>
      <authorList>
        <person name="Schmidt N."/>
        <person name="Ganskih S."/>
        <person name="Wei Y."/>
        <person name="Gabel A."/>
        <person name="Zielinski S."/>
        <person name="Keshishian H."/>
        <person name="Lareau C.A."/>
        <person name="Zimmermann L."/>
        <person name="Makroczyova J."/>
        <person name="Pearce C."/>
        <person name="Krey K."/>
        <person name="Hennig T."/>
        <person name="Stegmaier S."/>
        <person name="Moyon L."/>
        <person name="Horlacher M."/>
        <person name="Werner S."/>
        <person name="Aydin J."/>
        <person name="Olguin-Nava M."/>
        <person name="Potabattula R."/>
        <person name="Kibe A."/>
        <person name="Doelken L."/>
        <person name="Smyth R.P."/>
        <person name="Caliskan N."/>
        <person name="Marsico A."/>
        <person name="Krempl C."/>
        <person name="Bodem J."/>
        <person name="Pichlmair A."/>
        <person name="Carr S.A."/>
        <person name="Chlanda P."/>
        <person name="Erhard F."/>
        <person name="Munschauer M."/>
      </authorList>
      <dbReference type="PubMed" id="37794589"/>
      <dbReference type="DOI" id="10.1016/j.cell.2023.09.002"/>
    </citation>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH SARS-COV-2 NSP9</scope>
  </reference>
  <reference key="26">
    <citation type="submission" date="2007-07" db="PDB data bank">
      <title>Solution structure of the Tudor domain of staphylococcal nuclease domain-containing protein 1.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 704-800</scope>
  </reference>
  <reference evidence="16" key="27">
    <citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="3579" last="3589">
      <title>Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing.</title>
      <authorList>
        <person name="Li C.L."/>
        <person name="Yang W.Z."/>
        <person name="Chen Y.P."/>
        <person name="Yuan H.S."/>
      </authorList>
      <dbReference type="PubMed" id="18453631"/>
      <dbReference type="DOI" id="10.1093/nar/gkn236"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 340-888</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <comment type="function">
    <text evidence="1 5 9 10 13">Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (PubMed:18453631, PubMed:28546213). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (PubMed:28546213). Functions as a bridging factor between STAT6 and the basal transcription factor (PubMed:12234934). Plays a role in PIM1 regulation of MYB activity (PubMed:9809063). Functions as a transcriptional coactivator for STAT5 (By similarity).</text>
  </comment>
  <comment type="function">
    <text evidence="12">(Microbial infection) Functions as a transcriptional coactivator for the Epstein-Barr virus nuclear antigen 2 (EBNA2).</text>
  </comment>
  <comment type="function">
    <text evidence="11">(Microbial infection) Promotes SARS-CoV-2 RNA synthesis by binding to negative-sense RNA and the viral protein nsp9.</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="9 10">
      <text>Endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotide end-products.</text>
      <dbReference type="EC" id="3.1.31.1"/>
    </reaction>
  </comment>
  <comment type="subunit">
    <text evidence="1 5 7 10 12 13">Forms a ternary complex with STAT6 and POLR2A (PubMed:12234934). Associates with the RNA-induced silencing complex (RISC) (PubMed:14508492, PubMed:28546213). Interacts with the RISC components AGO2, FMR1 and TNRC6A (PubMed:14508492, PubMed:28546213). Interacts with GTF2E1 and GTF2E2 (PubMed:7651391). Interacts with PIM1 (PubMed:9809063). Interacts with STAT5 (By similarity). Interacts with SYT11 (via C2 2 domain); the interaction with SYT11 is direct (By similarity).</text>
  </comment>
  <comment type="subunit">
    <text evidence="6 11 12">(Microbial infection) Interacts with EAV NSP1 (PubMed:12917451). Binds to acidic transactivation domain of EBNA2 (PubMed:7651391). Interacts with SARS-CoV-2 NSP9 (PubMed:37794589).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1044112">
      <id>Q7KZF4</id>
    </interactant>
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
      <label>G3BP1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1044112">
      <id>Q7KZF4</id>
    </interactant>
    <interactant intactId="EBI-1046588">
      <id>Q86UE4</id>
      <label>MTDH</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1044112">
      <id>Q7KZF4</id>
    </interactant>
    <interactant intactId="EBI-527417">
      <id>Q96J94</id>
      <label>PIWIL1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="7 8">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="5 7 8 12">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="8">Melanosome</location>
    </subcellularLocation>
    <text evidence="5 8">In IL-4 stimulated cells colocalizes with STAT6 in the nucleus (PubMed:12234934). Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065).</text>
  </comment>
  <comment type="tissue specificity">
    <text evidence="12">Ubiquitously expressed.</text>
  </comment>
  <comment type="PTM">
    <text evidence="13">Phosphorylated by PIM1 in vitro.</text>
  </comment>
  <comment type="sequence caution" evidence="15">
    <conflict type="frameshift">
      <sequence resource="EMBL-CDS" id="AAA80488" version="1"/>
    </conflict>
    <text>The frameshift leads to wrong initiation.</text>
  </comment>
  <dbReference type="EC" id="3.1.31.1" evidence="9 10"/>
  <dbReference type="EMBL" id="U22055">
    <property type="protein sequence ID" value="AAA80488.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BT009785">
    <property type="protein sequence ID" value="AAP88787.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC017180">
    <property type="protein sequence ID" value="AAH17180.3"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS34747.1"/>
  <dbReference type="PIR" id="I38968">
    <property type="entry name" value="I38968"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_055205.2">
    <property type="nucleotide sequence ID" value="NM_014390.3"/>
  </dbReference>
  <dbReference type="PDB" id="2E6N">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=704-800"/>
  </dbReference>
  <dbReference type="PDB" id="2HQE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A/B=665-910"/>
  </dbReference>
  <dbReference type="PDB" id="2HQX">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.42 A"/>
    <property type="chains" value="A/B=665-910"/>
  </dbReference>
  <dbReference type="PDB" id="2O4X">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=679-895, B=705-795"/>
  </dbReference>
  <dbReference type="PDB" id="3BDL">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.90 A"/>
    <property type="chains" value="A=340-888"/>
  </dbReference>
  <dbReference type="PDB" id="3OMC">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.77 A"/>
    <property type="chains" value="A/B=650-910"/>
  </dbReference>
  <dbReference type="PDB" id="3OMG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.85 A"/>
    <property type="chains" value="A/B=650-910"/>
  </dbReference>
  <dbReference type="PDB" id="4QMG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A/B/C/D/E=16-339"/>
  </dbReference>
  <dbReference type="PDB" id="5M9O">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.45 A"/>
    <property type="chains" value="A=677-900"/>
  </dbReference>
  <dbReference type="PDB" id="7KNW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.65 A"/>
    <property type="chains" value="A/B/C/D=16-330"/>
  </dbReference>
  <dbReference type="PDB" id="7KNX">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A/B/C/D=16-330"/>
  </dbReference>
  <dbReference type="PDBsum" id="2E6N"/>
  <dbReference type="PDBsum" id="2HQE"/>
  <dbReference type="PDBsum" id="2HQX"/>
  <dbReference type="PDBsum" id="2O4X"/>
  <dbReference type="PDBsum" id="3BDL"/>
  <dbReference type="PDBsum" id="3OMC"/>
  <dbReference type="PDBsum" id="3OMG"/>
  <dbReference type="PDBsum" id="4QMG"/>
  <dbReference type="PDBsum" id="5M9O"/>
  <dbReference type="PDBsum" id="7KNW"/>
  <dbReference type="PDBsum" id="7KNX"/>
  <dbReference type="AlphaFoldDB" id="Q7KZF4"/>
  <dbReference type="SMR" id="Q7KZF4"/>
  <dbReference type="BioGRID" id="117974">
    <property type="interactions" value="325"/>
  </dbReference>
  <dbReference type="CORUM" id="Q7KZF4"/>
  <dbReference type="DIP" id="DIP-29613N"/>
  <dbReference type="ELM" id="Q7KZF4"/>
  <dbReference type="IntAct" id="Q7KZF4">
    <property type="interactions" value="83"/>
  </dbReference>
  <dbReference type="MINT" id="Q7KZF4"/>
  <dbReference type="STRING" id="9606.ENSP00000346762"/>
  <dbReference type="ChEMBL" id="CHEMBL3879865"/>
  <dbReference type="GlyCosmos" id="Q7KZF4">
    <property type="glycosylation" value="1 site, 1 glycan"/>
  </dbReference>
  <dbReference type="GlyGen" id="Q7KZF4">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q7KZF4"/>
  <dbReference type="MetOSite" id="Q7KZF4"/>
  <dbReference type="PhosphoSitePlus" id="Q7KZF4"/>
  <dbReference type="SwissPalm" id="Q7KZF4"/>
  <dbReference type="BioMuta" id="SND1"/>
  <dbReference type="DMDM" id="60415926"/>
  <dbReference type="REPRODUCTION-2DPAGE" id="IPI00140420"/>
  <dbReference type="jPOST" id="Q7KZF4"/>
  <dbReference type="MassIVE" id="Q7KZF4"/>
  <dbReference type="PaxDb" id="9606-ENSP00000346762"/>
  <dbReference type="PeptideAtlas" id="Q7KZF4"/>
  <dbReference type="ProteomicsDB" id="68706"/>
  <dbReference type="Pumba" id="Q7KZF4"/>
  <dbReference type="Antibodypedia" id="1126">
    <property type="antibodies" value="330 antibodies from 33 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="27044"/>
  <dbReference type="Ensembl" id="ENST00000354725.8">
    <property type="protein sequence ID" value="ENSP00000346762.3"/>
    <property type="gene ID" value="ENSG00000197157.11"/>
  </dbReference>
  <dbReference type="GeneID" id="27044"/>
  <dbReference type="KEGG" id="hsa:27044"/>
  <dbReference type="MANE-Select" id="ENST00000354725.8">
    <property type="protein sequence ID" value="ENSP00000346762.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_014390.4"/>
    <property type="RefSeq protein sequence ID" value="NP_055205.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003vmi.4">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:30646"/>
  <dbReference type="CTD" id="27044"/>
  <dbReference type="DisGeNET" id="27044"/>
  <dbReference type="GeneCards" id="SND1"/>
  <dbReference type="HGNC" id="HGNC:30646">
    <property type="gene designation" value="SND1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000197157">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="602181">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q7KZF4"/>
  <dbReference type="OpenTargets" id="ENSG00000197157"/>
  <dbReference type="PharmGKB" id="PA162404053"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000197157"/>
  <dbReference type="eggNOG" id="KOG2039">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00510000047270"/>
  <dbReference type="HOGENOM" id="CLU_005966_0_0_1"/>
  <dbReference type="InParanoid" id="Q7KZF4"/>
  <dbReference type="OMA" id="EKTCCTV"/>
  <dbReference type="OrthoDB" id="375531at2759"/>
  <dbReference type="PhylomeDB" id="Q7KZF4"/>
  <dbReference type="TreeFam" id="TF300615"/>
  <dbReference type="BRENDA" id="3.1.31.1">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="Q7KZF4"/>
  <dbReference type="Reactome" id="R-HSA-6802952">
    <property type="pathway name" value="Signaling by BRAF and RAF1 fusions"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q7KZF4"/>
  <dbReference type="SIGNOR" id="Q7KZF4"/>
  <dbReference type="BioGRID-ORCS" id="27044">
    <property type="hits" value="20 hits in 1165 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="SND1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q7KZF4"/>
  <dbReference type="GeneWiki" id="SND1"/>
  <dbReference type="GenomeRNAi" id="27044"/>
  <dbReference type="Pharos" id="Q7KZF4">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q7KZF4"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 7"/>
  </dbReference>
  <dbReference type="RNAct" id="Q7KZF4">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000197157">
    <property type="expression patterns" value="Expressed in body of pancreas and 208 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q7KZF4">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097433">
    <property type="term" value="C:dense body"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070062">
    <property type="term" value="C:extracellular exosome"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042470">
    <property type="term" value="C:melanosome"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031332">
    <property type="term" value="C:RNAi effector complex"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045296">
    <property type="term" value="F:cadherin binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004519">
    <property type="term" value="F:endonuclease activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016894">
    <property type="term" value="F:endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-EC"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004518">
    <property type="term" value="F:nuclease activity"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:1905172">
    <property type="term" value="F:RISC complex binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004521">
    <property type="term" value="F:RNA endonuclease activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003712">
    <property type="term" value="F:transcription coregulator activity"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010587">
    <property type="term" value="P:miRNA catabolic process"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006402">
    <property type="term" value="P:mRNA catabolic process"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001649">
    <property type="term" value="P:osteoblast differentiation"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010564">
    <property type="term" value="P:regulation of cell cycle process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031047">
    <property type="term" value="P:regulatory ncRNA-mediated gene silencing"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="CDD" id="cd00175">
    <property type="entry name" value="SNc"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="CDD" id="cd20433">
    <property type="entry name" value="Tudor_TDRD11"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="2.30.30.140">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="2.40.50.90">
    <property type="match status" value="5"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016685">
    <property type="entry name" value="Silence_cplx_Nase-comp_TudorSN"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035437">
    <property type="entry name" value="SNase_OB-fold_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016071">
    <property type="entry name" value="Staphylococal_nuclease_OB-fold"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002071">
    <property type="entry name" value="Thermonucl_AS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002999">
    <property type="entry name" value="Tudor"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR047386">
    <property type="entry name" value="Tudor_TDRD11"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12302">
    <property type="entry name" value="EBNA2 BINDING PROTEIN P100"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12302:SF28">
    <property type="entry name" value="STAPHYLOCOCCAL NUCLEASE DOMAIN-CONTAINING PROTEIN 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00565">
    <property type="entry name" value="SNase"/>
    <property type="match status" value="5"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00567">
    <property type="entry name" value="TUDOR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PIRSF" id="PIRSF017179">
    <property type="entry name" value="RISC-Tudor-SN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00318">
    <property type="entry name" value="SNc"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="SMART" id="SM00333">
    <property type="entry name" value="TUDOR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF50199">
    <property type="entry name" value="Staphylococcal nuclease"/>
    <property type="match status" value="5"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF63748">
    <property type="entry name" value="Tudor/PWWP/MBT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS01284">
    <property type="entry name" value="TNASE_2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50830">
    <property type="entry name" value="TNASE_3"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50304">
    <property type="entry name" value="TUDOR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0255">Endonuclease</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0540">Nuclease</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="initiator methionine" description="Removed" evidence="14 17 21 22 25">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000183180" description="Staphylococcal nuclease domain-containing protein 1">
    <location>
      <begin position="2"/>
      <end position="910"/>
    </location>
  </feature>
  <feature type="domain" description="TNase-like 1" evidence="4">
    <location>
      <begin position="18"/>
      <end position="166"/>
    </location>
  </feature>
  <feature type="domain" description="TNase-like 2" evidence="4">
    <location>
      <begin position="193"/>
      <end position="328"/>
    </location>
  </feature>
  <feature type="domain" description="TNase-like 3" evidence="4">
    <location>
      <begin position="341"/>
      <end position="496"/>
    </location>
  </feature>
  <feature type="domain" description="TNase-like 4" evidence="4">
    <location>
      <begin position="525"/>
      <end position="660"/>
    </location>
  </feature>
  <feature type="domain" description="Tudor" evidence="3">
    <location>
      <begin position="729"/>
      <end position="787"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="2">
    <location>
      <begin position="321"/>
      <end position="325"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="2">
    <location>
      <begin position="388"/>
      <end position="392"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylalanine" evidence="14 17 21 22 25">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="23">
    <location>
      <position position="103"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="18">
    <location>
      <position position="193"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="23">
    <location>
      <position position="240"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="23 24">
    <location>
      <position position="426"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="18">
    <location>
      <position position="641"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="23">
    <location>
      <position position="645"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="23 24">
    <location>
      <position position="779"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="20 23 24">
    <location>
      <position position="781"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="23">
    <location>
      <position position="785"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="19 23 24">
    <location>
      <position position="909"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="26">
    <location>
      <position position="513"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAA80488." evidence="15" ref="1">
    <original>L</original>
    <variation>V</variation>
    <location>
      <position position="274"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAA80488." evidence="15" ref="1">
    <original>LE</original>
    <variation>FQ</variation>
    <location>
      <begin position="707"/>
      <end position="708"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="20"/>
      <end position="27"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="29"/>
      <end position="31"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="33"/>
      <end position="36"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="40"/>
      <end position="43"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="46"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="54"/>
      <end position="56"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="61"/>
      <end position="64"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="71"/>
      <end position="73"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="79"/>
      <end position="90"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="94"/>
      <end position="102"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="108"/>
      <end position="117"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="120"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="123"/>
      <end position="129"/>
    </location>
  </feature>
  <feature type="strand" evidence="30">
    <location>
      <begin position="132"/>
      <end position="135"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="144"/>
      <end position="159"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="162"/>
      <end position="164"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="165"/>
      <end position="167"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="170"/>
      <end position="172"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="177"/>
      <end position="179"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="183"/>
      <end position="189"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="190"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="195"/>
      <end position="204"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="207"/>
      <end position="212"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="213"/>
      <end position="216"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="217"/>
      <end position="223"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="245"/>
      <end position="256"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="260"/>
      <end position="269"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="272"/>
      <end position="279"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="284"/>
      <end position="290"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="298"/>
      <end position="300"/>
    </location>
  </feature>
  <feature type="helix" evidence="30">
    <location>
      <begin position="301"/>
      <end position="303"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="308"/>
      <end position="320"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="324"/>
      <end position="326"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="341"/>
      <end position="351"/>
    </location>
  </feature>
  <feature type="turn" evidence="29">
    <location>
      <begin position="352"/>
      <end position="354"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="355"/>
      <end position="359"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="365"/>
      <end position="370"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="384"/>
      <end position="386"/>
    </location>
  </feature>
  <feature type="turn" evidence="29">
    <location>
      <begin position="387"/>
      <end position="389"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="392"/>
      <end position="395"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="399"/>
      <end position="410"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="414"/>
      <end position="425"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="432"/>
      <end position="435"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="438"/>
      <end position="445"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="450"/>
      <end position="456"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="459"/>
      <end position="462"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="476"/>
      <end position="488"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="492"/>
      <end position="494"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="511"/>
      <end position="523"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="526"/>
      <end position="544"/>
    </location>
  </feature>
  <feature type="turn" evidence="29">
    <location>
      <begin position="545"/>
      <end position="548"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="549"/>
      <end position="559"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="565"/>
      <end position="567"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="570"/>
      <end position="572"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="578"/>
      <end position="589"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="593"/>
      <end position="601"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="607"/>
      <end position="613"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="618"/>
      <end position="624"/>
    </location>
  </feature>
  <feature type="strand" evidence="29">
    <location>
      <begin position="627"/>
      <end position="630"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="632"/>
      <end position="634"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="640"/>
      <end position="653"/>
    </location>
  </feature>
  <feature type="helix" evidence="29">
    <location>
      <begin position="656"/>
      <end position="658"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="683"/>
      <end position="690"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="694"/>
      <end position="700"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="701"/>
      <end position="703"/>
    </location>
  </feature>
  <feature type="helix" evidence="28">
    <location>
      <begin position="706"/>
      <end position="720"/>
    </location>
  </feature>
  <feature type="turn" evidence="28">
    <location>
      <begin position="725"/>
      <end position="727"/>
    </location>
  </feature>
  <feature type="strand" evidence="28">
    <location>
      <begin position="735"/>
      <end position="739"/>
    </location>
  </feature>
  <feature type="turn" evidence="27">
    <location>
      <begin position="741"/>
      <end position="743"/>
    </location>
  </feature>
  <feature type="strand" evidence="28">
    <location>
      <begin position="745"/>
      <end position="755"/>
    </location>
  </feature>
  <feature type="strand" evidence="28">
    <location>
      <begin position="758"/>
      <end position="763"/>
    </location>
  </feature>
  <feature type="turn" evidence="28">
    <location>
      <begin position="764"/>
      <end position="766"/>
    </location>
  </feature>
  <feature type="strand" evidence="28">
    <location>
      <begin position="769"/>
      <end position="772"/>
    </location>
  </feature>
  <feature type="helix" evidence="28">
    <location>
      <begin position="774"/>
      <end position="776"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="777"/>
      <end position="779"/>
    </location>
  </feature>
  <feature type="helix" evidence="28">
    <location>
      <begin position="782"/>
      <end position="784"/>
    </location>
  </feature>
  <feature type="turn" evidence="28">
    <location>
      <begin position="786"/>
      <end position="788"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="794"/>
      <end position="798"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="807"/>
      <end position="821"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="824"/>
      <end position="832"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="835"/>
      <end position="837"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="839"/>
      <end position="844"/>
    </location>
  </feature>
  <feature type="turn" evidence="31">
    <location>
      <begin position="845"/>
      <end position="847"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="851"/>
      <end position="857"/>
    </location>
  </feature>
  <feature type="strand" evidence="31">
    <location>
      <begin position="860"/>
      <end position="863"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="869"/>
      <end position="871"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="872"/>
      <end position="887"/>
    </location>
  </feature>
  <feature type="helix" evidence="31">
    <location>
      <begin position="891"/>
      <end position="893"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="Q78PY7"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2"/>
  <evidence type="ECO:0000255" key="3">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00211"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00272"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="12234934"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="12917451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="14508492"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="17081065"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="18453631"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="28546213"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="37794589"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="7651391"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="9809063"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0000305" key="15"/>
  <evidence type="ECO:0007744" key="16">
    <source>
      <dbReference type="PDB" id="3BDL"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="17">
    <source>
      <dbReference type="PubMed" id="19413330"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="18">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="19">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="20">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="21">
    <source>
      <dbReference type="PubMed" id="22223895"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="22">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="23">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PubMed" id="25944712"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="27">
    <source>
      <dbReference type="PDB" id="2E6N"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="28">
    <source>
      <dbReference type="PDB" id="2HQX"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="29">
    <source>
      <dbReference type="PDB" id="3BDL"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="30">
    <source>
      <dbReference type="PDB" id="4QMG"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="31">
    <source>
      <dbReference type="PDB" id="5M9O"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="32">
    <source>
      <dbReference type="PDB" id="7KNW"/>
    </source>
  </evidence>
  <sequence length="910" mass="101997" checksum="D58BF200F3F3D628" modified="2004-07-05" version="1">MASSAQSGGSSGGPAVPTVQRGIIKMVLSGCAIIVRGQPRGGPPPERQINLSNIRAGNLARRAAATQPDAKDTPDEPWAFPAREFLRKKLIGKEVCFTIENKTPQGREYGMIYLGKDTNGENIAESLVAEGLATRREGMRANNPEQNRLSECEEQAKAAKKGMWSEGNGSHTIRDLKYTIENPRHFVDSHHQKPVNAIIEHVRDGSVVRALLLPDYYLVTVMLSGIKCPTFRREADGSETPEPFAAEAKFFTESRLLQRDVQIILESCHNQNILGTILHPNGNITELLLKEGFARCVDWSIAVYTRGAEKLRAAERFAKERRLRIWRDYVAPTANLDQKDKQFVAKVMQVLNADAIVVKLNSGDYKTIHLSSIRPPRLEGENTQDKNKKLRPLYDIPYMFEAREFLRKKLIGKKVNVTVDYIRPASPATETVPAFSERTCATVTIGGINIAEALVSKGLATVIRYRQDDDQRSSHYDELLAAEARAIKNGKGLHSKKEVPIHRVADISGDTQKAKQFLPFLQRAGRSEAVVEYVFSGSRLKLYLPKETCLITFLLAGIECPRGARNLPGLVQEGEPFSEEATLFTKELVLQREVEVEVESMDKAGNFIGWLHIDGANLSVLLVEHALSKVHFTAERSSYYKSLLSAEEAAKQKKEKVWAHYEEQPVEEVMPVLEEKERSASYKPVFVTEITDDLHFYVQDVETGTQLEKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSARLNLWRYGDFRADDADEFGYSR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>